clinical trials

Synlogic falls as it axes lead program
Synlogic falls as it axes lead program
BioCentury
Synlogic
clinical trials
SYNB1029
hyperammonemia
Flag link:
Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer
Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer
Endpoints
Nucana
clinical trials
Acelarin
metastatic pancreatic cancer
Flag link:
Juvenescence raises $100M to fund longevity assets to early readouts
Juvenescence raises $100M to fund longevity assets to early readouts
Fierce Biotech
Juvenescence
anti-aging
longevity
clinical trials
Flag link:
Many clinical trials for new cancer drugs didn’t include any data on race
Many clinical trials for new cancer drugs didn’t include any data on race
Stat
clinical trials
race
cancer
racial diversity
Flag link:
The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries
The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries
Endpoints
FDA
Syapse
EHRs
clinical trials
RWE
real world evidence
Flag link:
Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study
Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study
Endpoints
Mallinckrodt
clinical trials
hepatorenal syndrome
terlipressin
Flag link:
Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy
Fierce Biotech
Ziopharm Oncology
IL-12
gene therapy
glioblastoma
clinical trials
Flag link:
$60M B round to propel Landos through Phase II IBD trials
$60M B round to propel Landos through Phase II IBD trials
BioCentury
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Flag link:
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment
Pharmaforum
AstraZeneca
Merck
Lynparza
clinical trials
advanced ovarian cancer
ovarian cancer
Calquence
Flag link:
Deciphera soars as phase 3 cancer data tee up FDA filing
Deciphera soars as phase 3 cancer data tee up FDA filing
Fierce Biotech
Deciphera
clinical trials
ripretinib
gastrointestinal stromal tumors
Flag link:
Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity
Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity
RAPS.org
FDA
clinical trials
diversity
real world data
real world evidence
RWE
RWD
Flag link:
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer
Pharmaceutical Business Review
Sesen Bio
clinical trials
Vicinium
bladder cancer
Flag link:
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
CP WIre
89Bio
NASH
NAFLD
clinical trials
Flag link:
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
89Bio
NASH
NAFLD
clinical trials
Flag link:
Allakos sustains its gains on strength of GI readout
Allakos sustains its gains on strength of GI readout
BioCentury
Alllakos
clinical trials
eosinophilic gastritis
AK002
Flag link:
Astellas pushes non-hormonal menopause drug into phase 3
Astellas pushes non-hormonal menopause drug into phase 3
Pharmaforum
Astellas
menopause
clinical trials
fezolinetant
Flag link:
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
AstraZeneca, Merck herald PhIII prostate cancer win for Lynparza — overtaking Clovis, J&J in PARP race
Endpoints
Lynparza
AstraZeenca
Merck
prostate cancer
clinical trials
Flag link:
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Rhythm’s genetic obesity drug hits primary endpoint in phase 3
Fierce Biotech
Rhythm Pharmaceuticals
genetic obesity
clinical trials
setmelanotide
Flag link:
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Amid rising concern, pay-to-play clinical trials are drawing federal scrutiny
Stat
clinical trials
pay-to-play
Flag link:
Sanofi ends partnership with Lexicon after trial failure
Sanofi ends partnership with Lexicon after trial failure
In-Pharma Technologist
Sanofi
Lexicon Pharmaceuticals
clinical trials
Zynquista
diabetes
Flag link:

Pages